| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,684,000 | 1,916,000 | 1,908,000 | 2,064,000 | | Cost of Revenue | 1,461,000 | 890,000 | 978,000 | 845,000 | | | Gross Profit | 223,000 | 1,026,000 | 930,000 | 1,219,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (324,000) | 531,000 | 610,000 | 547,000 | | Non Recurring |
-
|
-
|
-
| 60,000 | | Others | 182,000 | 174,000 | 151,000 | 180,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 365,000 | 321,000 | 169,000 | 432,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,000 | 12,000 | 11,000 | 9,000 | | Earnings Before Interest And Taxes | 375,000 | 333,000 | 180,000 | 441,000 | | Interest Expense | 124,000 | 118,000 | 109,000 | 113,000 | | Income Before Tax | 251,000 | 215,000 | 71,000 | 328,000 | | Income Tax Expense | 83,000 | 70,000 | 8,000 | 113,000 | | Minority Interest |
-
|
-
| (6,000) | (11,000) | | | | Net Income From Continuing Ops | 168,000 | 145,000 | 57,000 | 204,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 168,000 | 145,000 | 57,000 | 204,000 | | Preferred Stock And Other Adjustments | (3,000) | (4,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $165,000 | $141,000 | $57,000 | $204,000 |
|
0.03% Nasdaq 
0.31%
Income Statement
